Drug Pipeline Report 2H 2024

IPD Analytics has released its Drug Pipeline and Trend Impact Report 2H 2024, a semiannual publication that highlights late-stage pipeline drugs with the potential to significantly affect the competitive landscape and payer drug spend across trending drug classes.

For each of the 37 drugs IPD identified as having potentially high impact, the report provides an assessment of clinical efficacy and safety, expected place in therapy, approval outlook, estimated cost, and information regarding the reimbursement and distribution channel.